acetate) is a prescription medication used to treat asthma
and other similar lung problems. It is part of a class of asthma drugs known as beta-adrenergic receptor agonists, or beta agonists for short.
Maxair inhalers will not be made, dispensed, or sold in the United States in their current form after December 31, 2013. Maxair contains chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. The U.S. Food and Drug Administration (FDA) has set this final date for the medication in order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer. The manufacturer of Maxair is working on a reformulated, CFC-free version, although it is not yet clear when that product will be available to consumers.
Maxair for Bronchospasm in Asthma or COPD
Asthma is a chronic disease that affects your airways, which are the tubes that carry air into and out of your lungs. If you have asthma, the inside walls of your airways are inflamed (swollen). The inflammation makes the airways very sensitive, and they tend to react strongly to things that you are allergic to or find irritating. When the airways react, they narrow and less air flows to your lungs. This is called bronchospasm. It causes asthma symptoms
like wheezing (a whistling sound when you breathe), coughing, tightness in the chest, and trouble breathing.
While there is no asthma cure, asthma can be controlled. There are many different asthma treatments
, and Maxair represents one of the most basic and most important types of treatment for asthma
relief. Maxair is a "rescue" asthma inhaler, which can help improve breathing very quickly. Even if you take asthma controller medications, it is important to always have a rescue asthma medication
available to relieve an attack.
Maxair is approved to both treat and prevent asthma attacks
. Because Maxair is short-acting, it is not necessarily the best asthma medication for preventing asthma attacks in general. However, it is an excellent medication for treating asthma attacks.